← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2023-06-06

Drug application

FDA Application #

ANDA213907

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE GEL, 5%

Active ingredients

DAPSONE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

TP ANDA HOLDINGS

Manufacturer

Trupharma, LLC

First approval

2023-06-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown